OpenAlex
PricingAboutJobs
Log inGet started
Work

Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment

HTML

Year: 2021
Type: article
Source: Annals of Internal Medicine
DOI: 10.7326/l20-1455
Authors: Rao N.V.S. Mamidi, Damayanthi Devineni, Don Sun, Yshai Yavin, Norman Rosenthal
Institution: Janssen Research & Development (United States)
Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions
Subfield: Toxicology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: rosuvastatin, canagliflozin, myotoxicity, drug-drug interactions, statins, SGLT2 inhibitors, rhabdomyolysis, type 2 diabetes, chronic kidney disease, CREDENCE trial, CANVAS trial, adverse drug reactions, pharmacokinetics, pharmacogenetics
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3137318924
FWCI:
Cites: 5
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security